Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

XATMEP 2.5 MG/ML ORAL SOLUTION

Methotrexate
$21.0695per ML
High Outlier

Strength

2.5 mg/mL

Manufacturer

Azurity Pharmaceuticals Inc.

NDC

52652200106

Classification

Brand

Dosage Form

SOLUTION

Route

ORAL

Last Updated

1/1/2025

Active Ingredients

METHOTREXATE

Approval Type

New Drug (NDA)

FDA Application

NDA208400

On Market Since

5/1/2017

Pharmacological Classes

Folate Analog Metabolic Inhibitor
Folic Acid Metabolism Inhibitors

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

N/A

5Y

N/A

All

+8.7%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

RASUVO 25 MG/0.5 ML AUTOINJ
Brand
59137054004•Medexus Pharma Inc.
$288.3819
per ML
RASUVO 20 MG/0.4 ML AUTOINJ
Brand
59137053004•Medexus Pharma Inc.
$361.0282
per ML
RASUVO 17.5 MG/0.35 ML AUTOINJ
Brand
59137052504•Medexus Pharma Inc.
$409.9292
per ML
OTREXUP 25 MG/0.4 ML AUTO-INJ
Brand
54436002504•Antares Pharma, Inc.
$475.8075
per ML
OTREXUP 17.5 MG/0.4 ML AUTOINJ
Brand
54436001704•Antares Pharma, Inc.
$476.9597
per ML
OTREXUP 20 MG/0.4 ML AUTO-INJ
Brand
54436002004•Antares Pharma, Inc.
$480.8553
per ML
RASUVO 15 MG/0.3 ML AUTOINJ
Brand
59137052004•Medexus Pharma Inc.
$482.2921
per ML
OTREXUP 15 MG/0.4 ML AUTO-INJ
Brand
54436001504•Antares Pharma, Inc.
$484.2097
per ML
RASUVO 12.5 MG/0.25 ML AUTOINJ
Brand
59137051504•Medexus Pharma Inc.
$574.8679
per ML
RASUVO 10 MG/0.2 ML AUTOINJ
Brand
59137051004•Medexus Pharma Inc.
$721.8144
per ML

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy